IDPC Publications

A key role and added value of IDPC is the production of policy analysis for a broad range of audiences including academia, civil society and policy makers. The majority of these publications are collaborations with members and partners, and are translated into multiple languages to support and facilitate advocacy.

Results 157 to 168 of 466

23 April 2018

Medicinal cannabis policies and practices around the world

IDPC and MUCD provide an overview of the key models of regulation and offer general recommendations to improve public policies in areas where legislation is already in place and to improve decision-making in countries where reform is pending.

7 March 2018

Drug dependence treatment in Thailand: Progress against persistent concerns

This paper provides recommendations for overcoming challenges in light of current policies and practices in Thailand so that the drug treatment system can result in improved health and human rights outcomes for people who use drugs and people dependant on drugs.

5 March 2018

What comes next? Post-UNGASS options for 2019 (Version 5)

IDPC suggests avenues to ensure that the outcome of the 2019 High Level Ministerial Segment reflects international commitments and debates.

5 March 2018

The IDPC ‘UNGASS Asks’: Progress made and remaining challenges

IDPC revisits the progress made against the "Asks" developed by the network in view of the UNGASS of 2016.

26 January 2018

IDPC analysis of the UNODC World Drug Report 2017

This year’s report, which includes content like interactive maps and data sets, is one of the agency’s most thorough and accessible publications to date.

15 January 2018

What comes next? Post-UNGASS options for 2019 - Version 4

IDPC suggests avenues to ensure that the outcome of the 2019 High Level Ministerial Segment reflects international commitments and debates.

23 November 2017

Drug laws in West Africa: A review and summary

IDPC and WACD summarise and review existing drug legislation from the 15 ECOWAS member states, as well as Mauritania and Morocco, concluding on the need for reform to align domestic laws with regional and international commitments.

2 November 2017

IDPC contribution for the pre-review of CBD and Tramadol at the 39th WHO Expert Committee on Drug Dependence

In this advocacy note, IDPC offers some analysis and key recommendations on CBD and tramadol to inform the ECDD’s meeting set to take place in November 2017.

2 November 2017

IDPC contribution for the upcoming report of the Office of the High Commissioner for Human Rights (OHCHR) on 'Civil society space in multilateral institutions'

IDPC reviews the successes and obstacles of civil society participation in the 2016 UNGASS as a case study to feed into the upcoming OHCHR report.

2 November 2017

IDPC progress report 2016-2017

This IDPC progress report provides an overview of our activities between 2016 and 2017, including our continuing efforts to build capacity for drug policy advocacy and the numerous publications and resources produced during this period.

27 October 2017

IDPC contribution for the upcoming report of the Office of the High Commissioner for Human Rights (OHCHR) on the Sustainable Development Goals and Health

IDPC calls upon the OHCHR to promote harm reduction, reiterate its call for the decriminalisation of drug use and end all other forms of inhumane and disproportionate punishment.

28 September 2017

Edging forward: How the UN’s language on drugs has advanced since 1990

In an effort to help digest and contextualise the UNGASS Outcome Document, this IDPC briefing paper explores a selection of key themes by analysing the consensus-based language agreed by UN member states during high-level meetings over the last quarter of a century.